v3.26.1
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)
12 Months Ended
Dec. 31, 2025
Restructuring Cost and Reserve [Line Items]  
SCHEDULE OF EXERCISE PRICE OF STOCK OPTIONS

The following table presents information related to stock options as of December 31, 2025:

 

Options Outstanding   Options Exercisable 
        Weighted Average   Exercisable 
Exercise   Number of   Remaining Life   Number of 
Price   Options   In Years   Options 
$ Under 9.99    2,715,000    8.7    2,715,000 
  10.00-19.99    15,000    7.4    15,000 
  20.00-49.99    3,000    3.2    3,000 
  50.00-69.99    3,000    4.0    3,000 
       2,736,000    8.7    2,736,000 
SCHEDULE OF STOCK OPTION ACTIVITY

A summary of the stock option activity and related information for the Plan for the years ended December 31, 2025 and 2024 is as follows:

 

   Shares  

Weighted

Average

Exercise Price

  

Weighted

Average Remaining

Contractual Term

  

Aggregate

Intrinsic Value

 
Outstanding as of January 1, 2024   603,229   $25.67    6.7   $- 
Issued   2,400,000   $0.45        $- 
Forfeited/expired   (488,029)  $28.97         - 
Outstanding as of December 31, 2024   2,515,200   $0.96    9.6   $2,501,040 
Issued   250,000   $0.84    9.3   $- 
Forfeited/expired   (29,200)  $17.34    -    - 
Outstanding at December 31, 2025   2,736,000   $0.78    8.7   $6,744,540 
Exercisable at December 31, 2025   2,736,000   $0.78    8.7   $6,744,540 
SCHEDULE OF OPTIONS GRANTED ASSUMPTIONS USING BLACK-SCHOLES OPTION

During the year ended December 31, 2025, the Company granted options to purchase shares of its common stock, which were valued using the Black-Scholes option pricing model. The following assumptions were used to calculate the fair value of the options granted during the years ended December 31, 2025, and 2024:

 

Assumption  2025   2024 
Weighted average grant date fair value  $0.80   $0.40 
Expected volatility   122.43%   135.60%
Risk-free interest rate   4.32%   3.50%
Expected dividend yield   0.00%   0.00%
Expected Term (in years)   10.0    5.5 
SCHEDULE OF INFORMATION RELATED TO WARRANTS

The following table summarizes information with respect to outstanding warrants to purchase common stock of Streamex Corp. as of December 31, 2025:

 

Exercise Price   Number of Warrants   Expiration Date
$0.3000    11,982   Nov-29
 0.9547    665,900   Sep-28
 3.3640    117,828   Jul-29
 4.0660    25,000   Nov-32
 4.4550    107,483   Jun-28
 4.6626    5,580   Apr-29
 4.9252    49,550   Mar-29
 4.9290    71,593   Mar-29
 5.1358    99,243   Jul-28
 7.1810    83,270   Jul-28
 7.5020    9,846   Jul-28
 7.9630    21,369   Aug-28
 9.0000    21,709   Jun-27
 9.5960    84,390   Jan-29
 10.0992    19,118   Aug-28
 10.2600    51,705   Sep-28
 10.4678    84,296   Sep-28
 11.3000    40,417   Oct-28
 13.2800    96,198   Nov-28
 48.0000    12,500   Jul-26
 61.6000    56,892   Nov-27
      1,735,869    
SCHEDULE OF WARRANT ACTIVITY

A summary of the warrant activity for the years ended December 31, 2025 and 2024 is as follows:

 

   Shares  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
Outstanding as of January 1, 2024   2,748,371   $7.40    3.7   $1,717 
Issued   2,202,697   $2.00    5.0    - 
Exercised   (51,352)  $0.30    -    - 
Outstanding as of December 31, 2024   4,899,716   $4.88    3.5   $405 
Issued   758,514   $0.95    3.0    - 
Forfeited/expired   (886,206)  $41.32    -    - 
Repurchased for cash (Fundamental Transaction election)   (678,778)  $2.07    -    - 
Exercised   (2,357,377)  $2.41    -    - 
Outstanding at December 31, 2025   1,735,869   $6.94    2.8   $1,415 
Vested and expected to vest at December 31, 2025   1,735,869   $6.94    2.8   $1,415 
Exercisable at December 31, 2025   1,735,869   $6.94    2.8   $1,415 
SCHEDULE OF RESTRICTED STOCK ACTIVITY

The following table summarizes the restricted stock activity for the years ended December 31, 2025 and 2024:

 

Restricted shares issued as of January 1, 2024   163,250 
Granted   4,605,000 
Vested and issued   (3,075,659)
Forfeited   (306,752)
Restricted shares issued as of December 31, 2024   1,385,839 
Granted   19,373,980 
Vested and issued   (18,658,156)
Forfeited   (64,163)
Restricted shares issued as of December 31, 2025   2,037,500 
Comprised of:     
Vested restricted shares as of December 31, 2025   - 
Unvested restricted shares as of December 31, 2025   2,037,500 

Viral Clear Pharmaceuticals Inc [Member]  
Restructuring Cost and Reserve [Line Items]  
SCHEDULE OF RESTRICTED STOCK ACTIVITY

The following table summarizes the restricted stock activity for the years ended December 31, 2025 and 2024:

 

Restricted shares issued as of January 1, 2024   1,078,679 
Forfeited   (400,000)
Restricted shares outstanding at December 31, 2024   678,679 
Forfeited   - 
Total restricted shares outstanding at December 31, 2025   678,679 
      
Comprised of:     
Vested restricted shares as of December 31, 2025   678,679 
Unvested restricted shares as of December 31, 2025   - 
Total   678,679 
Viral Clear Pharmaceuticals Inc [Member]  
Restructuring Cost and Reserve [Line Items]  
SCHEDULE OF INFORMATION RELATED TO WARRANTS

The following table presents information related to warrants (ViralClear) at December 31, 2025:

 

Exercise   Number   Expiration 
Price   Outstanding   Date 
$5.00    473,772    November 2027 
SCHEDULE OF WARRANT ACTIVITY

A summary of the warrant activity for year ended December 31, 2025 is as follows:

  

           Weighted-Average 
           Remaining 
       Weighted-Average   Contractual 
   Shares   Exercise Price   Term 
Outstanding at January 1, 2024   480,347   $5.07    3.9 
Forfeited/expired   -           
Outstanding at December 31, 2024   480,347   $5.07    2.9 
Forfeited/expired   (6,575)  $10.00      
Outstanding at December 31, 2025   473,772   $5.00    1.9 
Exercisable at December 31, 2025   473,772   $5.00    1.9 
BioSig AI Sciences, Inc. [Member]  
Restructuring Cost and Reserve [Line Items]  
SCHEDULE OF INFORMATION RELATED TO WARRANTS

The following table summarizes information with respect to outstanding warrants to purchase common stock of BioSig AI at December 31, 2025:

 

Exercise   Number   Expiration 
Price   Outstanding   Date 
$1.00    130,500    June-July 2028